Executive team

Agustin Fernandez


Chief Executive Officer

David Brindley, DPhil, MEng; PG Cert, (IP), RAC (US), FRSA, FRSB


Chief Regulatory & IP Officer

Edward Gershburg, PhD


Chief Technology Officer

Luis Rios-Nogales, MD, PhD, MBA


Chief Development and Medical Officer

Kelly Smith MD, MHS


Global Safety Officer

Gerhard Hager, PhD


Head of Non-Clinical Development

Kerstin Westritschnig, MD


Head of Clinical Development

Konstantin Kousoulas PhD


VP of Scientific Affairs

Cecilia Huaman, MPH, Ph.D


Director Immunology and Diagnostics

Quinn Steele


Head of GxP and Regulatory E-Systems

Diane Abbitt, Esq


Patient Advocate

David B. Mixner


Diversity Outreach Advisor

Bob Lemon, B.S., MBA


CMC Project Manager

Aziz Friedrich


Chief Financial Officer & Vice President of Operations

Scientific Advisory Board

Paul Predki, PhD


SAB Chair, Biotech executive, co-founder and CTO of Iridia Inc.

Rahul Singhvi, ScD, MBA


Operating Partner, Flagship Pioneering

Lional Raj, MD


Medical Director, Department of Cornea and Refractive Surgery, Dr. Agarwal’s Eye Hospital, India

Daniel J.J. Carr, PhD


Stanton L Young Endowed Chair in Ophthalmology, George Lynn Cross Research Professor, University of Oklahoma Health Sciences Center

Georg Holländer, MA, MD, FMedSci, FRCPCH, FHM Pediatrics


Chair, Department of Pediatrics, University of Oxford, Oxford, UK

Todd Margolis, MD, PhD


Chair, Department of Ophthalmology, Washington University, St. Louis, MO, USA

Jim Robinson, BS, MS


Industry Consultant

David I. Bernstein, MD, MA


Professor of Pediatric Infectious Diseases at Cincinnati Children’s Hospital Medical Center